Testosterone is the quintessential male hormone (androgen), and it’s a busy one, helping to regulate intimate function, ...

Toronto-based internal medicine specialist Dr Siobhan Deshauer has revealed the subtle and unlikely signs of deadly liver ...

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.

A RED flag sign in your pee could mean you have a 25 per cent higher risk of dementia, scientists say. Having high levels of the protein albumin in your pee could mean you’re at increased ...

Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...

I am an active male in my 70s and in good health. I exercise, eat healthy, and keep my weight down, and my blood work comes back perfect.

Statistically significant responder rate achieved at 12 weeks with zero contribution from rescue therapy (PRN) and further improvement sustained ...

Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...

Mineralys achieved positive Phase 2 results in CKD patients with hypertension. Click here to find out why MLYS stock is a ...

The FDA said Dexcom issued a correction for certain continuous glucose monitor apps due to a software design error that didn't alert users to unexpected sensor failure -- the most serious type of ...

"MBX to advance hypoparathyroidism drug to Phase III trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

Recent clinical trial update news from Aethlon Medical, Inc. (NASDAQ: AEMD), Envoy Medical, Inc. (NASDAQ: COCH), Soligenix, ...